KD Logo

A company insider recently sold 75,000 shares of Edgewise Therapeutics Inc [EWTX]. Should You Sale?

NUE

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Edgewise Therapeutics Inc shares valued at $2,120,101 were sold by Russell Alan J on Sep 20 ’24. At $28.27 per share, Russell Alan J sold 75,000 shares. The insider’s holdings dropped to 12,719 shares worth approximately $0.44 million following the completion of this transaction.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Also, MOORE JOHN R sold 50,000 shares, netting a total of over 1,418,510 in proceeds. Following the sale of shares at $28.37 each, the insider now holds 3,252 shares.

Before that, MOORE JOHN R had sold 20,922 shares from its account. In a trade valued at $578,064, the General Counsel traded Edgewise Therapeutics Inc shares for $27.63 each. Upon closing the transaction, the insider’s holdings decreased to 20,922 shares, worth approximately $0.11 million.

As published in their initiating research note from Piper Sandler on March 07, 2024, Edgewise Therapeutics Inc [EWTX] has been an Overweight and the price target has been revised to $48. Analysts at Truist started covering the stock with ‘”a Buy”‘ outlook in a report released in early May. As of August 25, 2022, Goldman has decreased its “Neutral” rating to a “Sell” for EWTX. Earlier on April 13, 2022, RBC Capital Mkts initiated its rating. Their recommendation was “an Outperform” for EWTX stock.

Analyzing EWTX Stock Performance

During the last five days, there has been a drop of approximately -0.63%. Over the course of the year, Edgewise Therapeutics Inc shares have jumped approximately 218.19%. Nevertheless, trading volume fell to 0.55 million shares from 0.76 million shares the previous day.

Support And Resistance Levels for Edgewise Therapeutics Inc (EWTX)

RSI (Relative Strength Index) is 73.53 on the 14-day chart, showing overbought technical sentiment.

Most Popular